NCT06309862View on ClinicalTrials.gov

Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Cardio-OncologyCardiomyopathy Due to Drug
Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Center, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER